Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 25;308(4):339-42.
doi: 10.1001/jama.2012.5927.

Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy

Baligh R Yehia  1 , John A Fleishman, Joshua P Metlay, Richard D Moore, Kelly A Gebo
Affiliations

Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy

Baligh R Yehia et al. JAMA. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Moore reported receiving or having grants pending with the National Institutes of Health, Pfizer, and Bristol-Meyers Squibb. Dr Gebo reported having served as a consultant, served on a scientific advisory board, and having received research funding from Tibotec. No other disclosures were reported.

References

    1. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. - PMC - PubMed
    1. Centers for Disease Control and Prevention (CDC) Vital signs: HIV prevention through care and treatment—United States. MMWR Morb Mortal Wkly Rep. 2011;60:1618–1623. - PubMed
    1. Moore RD, Bartlett JG. Dramatic decline in the HIV-1 RNA level over calendar time in a large urban HIV practice. Clin Infect Dis. 2011;53(6):600–604. - PMC - PubMed
    1. Gill VS, Lima VD, Zhang W, et al. Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection. Clin Infect Dis. 2010;50(1):98–105. - PMC - PubMed
    1. Department of Health and Human Services; Panel on Antiretroviral Guidelines for Adults and Adolescents. [Accessed March 30, 2012.];Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http://www.aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treat...

Publication types